Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi-Un Pae

Showing results (291-300 of 387) with videos related to

Pageof 39
Sort By:
Human Psychopharmacology|January 13, 2004
Switching to quetiapine in patients with acute mania who were intolerant to risperidoneChi-Un Pae, Kyong-Uk Lee, Jung-Jin Kim, et al.
Clinical Neuropharmacology|June 11, 2009
Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trialChi-Un Pae, David M Marks, Prakash S Masand, et al.
Current Therapeutic Research, Clinical and Experimental|April 3, 2014
Paroxetine for patients with undifferentiated somatoform disorder: A prospective, open-label, 8-week pilot studyChangsu Han, David M Marks, Chi-Un Pae, et al.
Journal of Clinical Psychopharmacology|April 18, 2015
A 13-week, randomized double-blind, placebo-controlled, cross-over trial of ziprasidone in bipolar spectrum disorderAshwin A Patkar, Chi-Un Pae, Paul A Vöhringer, et al.
Military Medicine|December 13, 2006
Interrelationships among pain, disability, and psychological factors in young Korean conscripts with lumbar disc herniationTae-Suk Kim, Chi-Un Pae, Chang-Ki Hong, et al.
Neuropsychobiology|March 23, 2004
Monocyte chemoattractant protein-1 promoter -2518 polymorphism may have an influence on clinical heterogeneity of bipolar I disorder in the Korean populationChi-Un Pae, Jung-Jin Kim, Hye-Sook Yu, et al.
Contemporary Clinical Trials|December 17, 2008
The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatryChangsu Han, Kyung-phil Kwak, David M Marks, et al.
Neuropsychobiology|November 19, 2011
Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophreniaChi-Un Pae, Alberto Chiesa, Stefano Porcelli, et al.
Neuroscience Letters|November 19, 2011
Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to antipsychotic treatment in patients with schizophreniaConcetta Crisafulli, Alberto Chiesa, Diana De Ronchi, et al.
Clinical Drug Investigation|March 19, 2008
Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder: a 12-week prospective, open-label, randomized, parallel-group trialChangsu Han, Chi-Un Pae, Bun-Hee Lee, et al.
Pageof 39

Showing results (291-300 of 387) with videos related to

Sort By:
Pageof 39
Human Psychopharmacology|January 13, 2004
Switching to quetiapine in patients with acute mania who were intolerant to risperidoneChi-Un Pae, Kyong-Uk Lee, Jung-Jin Kim, et al.
Clinical Neuropharmacology|June 11, 2009
Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trialChi-Un Pae, David M Marks, Prakash S Masand, et al.
Current Therapeutic Research, Clinical and Experimental|April 3, 2014
Paroxetine for patients with undifferentiated somatoform disorder: A prospective, open-label, 8-week pilot studyChangsu Han, David M Marks, Chi-Un Pae, et al.
Journal of Clinical Psychopharmacology|April 18, 2015
A 13-week, randomized double-blind, placebo-controlled, cross-over trial of ziprasidone in bipolar spectrum disorderAshwin A Patkar, Chi-Un Pae, Paul A Vöhringer, et al.
Military Medicine|December 13, 2006
Interrelationships among pain, disability, and psychological factors in young Korean conscripts with lumbar disc herniationTae-Suk Kim, Chi-Un Pae, Chang-Ki Hong, et al.
Neuropsychobiology|March 23, 2004
Monocyte chemoattractant protein-1 promoter -2518 polymorphism may have an influence on clinical heterogeneity of bipolar I disorder in the Korean populationChi-Un Pae, Jung-Jin Kim, Hye-Sook Yu, et al.
Contemporary Clinical Trials|December 17, 2008
The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatryChangsu Han, Kyung-phil Kwak, David M Marks, et al.
Neuropsychobiology|November 19, 2011
Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophreniaChi-Un Pae, Alberto Chiesa, Stefano Porcelli, et al.
Neuroscience Letters|November 19, 2011
Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to antipsychotic treatment in patients with schizophreniaConcetta Crisafulli, Alberto Chiesa, Diana De Ronchi, et al.
Clinical Drug Investigation|March 19, 2008
Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder: a 12-week prospective, open-label, randomized, parallel-group trialChangsu Han, Chi-Un Pae, Bun-Hee Lee, et al.
Pageof 39